Optimization of design transfer from device development to final assembly

https://view6.workcast.net/register?cpak=4955296047411557

Development of drug delivery devices goes through numerous critical stages. Of these stages, design transfer plays a significant role as part of the product lifecycle to assure the final device design is properly translated into production specifications. Given the complexity of a drug delivery device project, a sound design transfer process is necessary to meet the project timeline and cost.

Pharma and biotech companies then have the option to establish a final assembly and packaging infrastructure internally or they can partner up with third party contract manufacturers, or they can work with end-to-end solution providers like SHL to execute the final stage of their combination product projects.

SHL’s Taras and Amy will explore the key differences, advantages, and potential project risks associated with each route. The speakers will also discuss the role of an integrated process development strategy – referencing SHL as an example – in developing an optimal design transfer and manufacturing solution to transform engineering designs into manufactured drug delivery devices successfully and consistently.

Key topics that will be covered in this webinar include:

• Design transfer in the drug delivery device industry
• Critical factors to consider in the design transfer processes
• Comparison of different final assembly and packaging options
• SHL Medical’s process development strategy and capabilities

The webinar will begin at 3 PM GMT / 10 AM EST / 11 PM CST on February 24. Register today to book your place.

With Taras Seniuch (SHL Medical, Head of Account Management, Americas) and Amy Hartl (SHL Medical, Director of Process Development)